Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001573781 | SCV000530682 | likely benign | not provided | 2020-11-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000950980 | SCV001097327 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840553 | SCV002102157 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840554 | SCV002102158 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840555 | SCV002102159 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840552 | SCV002102160 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365542 | SCV002661740 | likely benign | Cardiovascular phenotype | 2019-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002488952 | SCV002803201 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-08-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573781 | SCV004150226 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TTN: BP4 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573781 | SCV001800137 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000428661 | SCV001923059 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573781 | SCV001964582 | likely benign | not provided | no assertion criteria provided | clinical testing |